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a  b  s  t  r  a  c  t
Human papillomavirus (HPV) infection is common in sexually active women and viral per-
sistence may cause intraepithelial lesions and eventually progress to cervical cancer (CC).
The  present study aimed to investigate epidemiological factors related to HPV infection
and to evaluate viral persistence and CC precursor lesions frequencies in women from a
city in the countryside of South Brazil. Three hundred women were recruited from a pri-
mary public health care clinic. The patients were interviewed and underwent sampling
with  cervical brushes for HPV-DNA detection/typing by a PCR-based assay and cytological
analysis by Pap smear test. HPV was detected in 47 (15.7%) women. HPV infection was  sig-
niﬁcantly associated with young age (<30 years) and low socio-economic status. Seventeen
(5.7%) women presented cytological abnormalities, three of them with precursor CC intraep-
ithelial lesions. A subgroup of 79 women had been previously analyzed and thirteen (16.4%)
were persistently infected, two with precursor CC intraepithelial lesions and high-risk HPV
types  infection (both of them without cervical abnormalities in the ﬁrst exam). In conclu-
sion, HPV infection was associated with young age (<30 years) and low family income; viralpersistence was low (16.4%) but related to CC precursor lesions; and HPV-DNA high risk
types detection would help to screen CC in the population.
© 2015 Elsevier Editora Ltda. All rights reserved.
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auses of sexually transmitted diseases in the worldwide.
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HPV infection is usually transient and most people elimi-
nate the virus from the body with the effective action of
the immune system after 5.1–15.4 months.2 However, HPV
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persistence can cause benign lesions, known as warts (in dif-
ferent parts of the body), or low/high grade intra-epithelial
lesions (LSIL/HSIL) that can progress to cancer, mainly in the
uterine cervix.3 Further, HPV persistence and consequently
cervical cancer (CC) depends on other factors, such as age,
high parity, smoking, long-term use of contraceptives, sex-
ual behavior and co-infection with other sexually transmitted
infectious agents.4
HPV prevalence ranges from 13.7% to 54.3% according
to the studied population and geographic area in Brazil
reviewed by.5 However, main epidemiological studies have
been performed in the capitals and metropolitan cities. These
studies demonstrated that HPV infection was associated
with multiple sexual partners6; young age, more  lifetime sex
partners and abnormal vaginal ﬂora7 and non-stable sex-
ual partners.8 HPV persistence also presented frequencies as
different as 19.2% in Porto Alegre (Rio Grande do Sul state)
and 59.6% in Ouro Preto (Minas Gerais state) in two stud-
ies performed in primary public health care clinics from
Brazil.9,10
This study aimed to investigate epidemiological aspects
associated with HPV infection and to evaluate HPV persistence
in women from the city of Cruz Alta and surrounding small
localities. This countryside region is located in the North of
the Rio Grande do Sul (the southern most state in Brazil) and
it is more  than 300 km away from the respective capital city
(Porto Alegre).
Methodology
Study  population  and  sample  collection
A cross-sectional study was conducted with 300 women who
accepted to participate in the study while attending for CC
screening in a primary public health care clinic (Center for
Women and Children) in the city of Cruz Alta (Rio Grande do
Sul State, Brazil) from January 2012 to April 2013. Epidemiologi-
cal informations (socio-demographic, behavioral, and clinical)
were obtained from a standardized individual questionnaire
that was administered by a trained interviewer in a private
room. The research project was approved by the Research
Ethics Committee of the University of Cruz Alta (Protocol No.
078.0.417-09).
After each participant gave informed consent, cervical
samples were collected from all participants for HPV-DNA
testing and cytological analysis. Clinical samples were col-
lected by scraping the ectocervix and endocervix of each
patient with an endocervical brush, smeared on a glass slide
(that was ﬁxed immediately with polyethylene glycol for cyto-
logical examination) and after stored in a buffer solution
(EDTA pH 8.0 0.01 M,  SDS 0.03 M),  and stored at −20 ◦C until
analysis.
Women also enrolled in a previous report11 or with two
visits in this study (minimum interval of twelve months) were
identiﬁed to evaluate HPV persistence. A total of 79 (26.3%)
women attended these criteria (57 evaluated in the previous
study and 22 analyzed twice in this study) and composed a
subgroup to investigate HPV persistence. 0 1 6;2  0(1):61–68
The clinical management of the patients was in accor-
dance with the “Brazilian classiﬁcation for cervical reports
and recommended procedures: recommendations for health
professionals”.12 This protocol do not establish HPV testing in
the routine screening, so results of HPV types were not used
in the management of the patients.
HPV-DNA  detection  and  typing
HPV-DNA testing was performed by nested polymerase
chain reaction (nested-PCR) and restriction fragment length
polymorphism (RFLP) as previously described.13 Samples pre-
senting insufﬁcient DNA for HPV typing were classiﬁed as
inconclusive. Results were interpreted by two  independent
analysts and HPV types were classiﬁed into high-risk (HR) and
low-risk (LR).14
Cytological  analysis
The cytological analysis was performed by conventional
Pap smear test evaluated by two independent cytologists
(conﬂicting results were submitted to a third evaluation). Cell
abnormalities were classiﬁed according to the Bethesda Sys-
tem 2001.15 Basically, it classiﬁes the modiﬁed cells into nine
categories (ﬁve to squamous and four to glandular cells): (1)
squamous cell carcinoma, (2) high-grade squamous intraep-
ithelial lesion (HSIL), (3) low-grade squamous intraepithelial
lesion (LSIL), (4) atypical squamous cells of undetermined sig-
niﬁcance (ASC-US), (5) atypical squamous cells that cannot
exclude HSIL (ASC-H), (6) adenocarcinoma, (7) endocervical
adenocarcinoma in situ, (8) atypical glandular cells (AG), and
(9) atypical glandular cells not otherwise speciﬁed (AG-NOS).
Normal cells were deﬁned as negative for intraepithelial lesion
and malignancy (NILM).
HPV  persistence
Women with two evaluations were classiﬁed into four cat-
egories according to the HPV infection status: (1) persistent
infection: HPV-DNA positive in both assessments; (2) conver-
sion: HPV-DNA negative in the ﬁrst visit and HPV-DNA positive
in the follow-up; (3) elimination (clearance): HPV-DNA pos-
itive only in the ﬁrst evaluation; (4) without HPV infection:
HPV-DNA negative in both visits.
Statistical  analysis
Data analysis was conducted using the SPSS version 17.0 soft-
ware  (SPSS Inc., USA). Association between HPV infection
status and other variables was determined with the chi-square
test. Multivariate models were conducted using a modiﬁed
Poisson regression16 to test the independent associations of
HPV infection with socio-demographic, behavioral and clin-
ical characteristics. Associations that presented values of p
between 0.05 and 0.15 in bivariate analysis were regarded
as having borderline signiﬁcance and were included in the
modeling of confounding factors. All p values presented are
two-tailed and the values of p < 0.05 were considered statisti-
cally signiﬁcant.
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Table 1 – Analysis of socio-demographic characteristics in women according to HPV status.
Variables Overall (n = 300) Without HPV (n = 253) With HPV (n = 47) p-Valuea
Age (years) 0.003
≤19 28 (9.3) 19 (7.5) 9 (19.1)
20–29 56 (18.7) 41 (16.2) 15 (31.9)
30–39 59 (19.7) 50 (19.8) 9 (19.1)
40–49 60 (20.0) 57 (22.5) 3 (6.4)
50–59 59 (19.7) 53 (20.9) 6 (12.8)
≥60 38 (12.7) 33 (13.0) 5 (10.6)
Schoolingb 0.247
Elementary or lower education 178 (60.8) 153 (62.2) 25 (53.2)
Medium or higher education 115 (39.2) 93  (37.8) 22 (46.8)
Total household income (in Brazilian minimum monthly wage) <0.001
≤1 126 (42.0) 93 (36.8) 33 (70.2)
2–3 162 (54.0) 151 (59.7) 11 (23.4)
>3 12 (4.0) 9 (3.6) 3 (6.4)
Marital statusb 0.014
Married or stable union 56 (56.6) 54 (60.7) 2 (20.0)
Single/divorced/widowed 43 (43.4) 35 (39.3) 8 (80.0)
Childrenb 0.016
Yes 232 (78.1) 203 (80.6) 29 (64.4)
No 65 (21.9) 49 (19.4) 16 (35.6)
Data are reported as number with percent in parentheses.
a 2 test was used to compare between participants.
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esults
f the 300 women evaluated in the study, HPV was detected in
7 (15.7%). Of these positive samples, 26 (55.3%) had single and
0 (21.3%) multiple HPV type infections (it was not possible to
etermine the type in the remaining 11 positive samples). A
otal of 23 viral types were identiﬁed; including 15 (65.2%) HR
nd 8 (34.8%) LR. Types HR most frequents were 16 (n = 6), 31
n = 4), 45 (n = 4) and 56 (n = 3). Other HR types were 18, 35, 39,
2, 53, 58, 59, 68, 70, 73 and 82. Types LR most frequents were
 and 81 (n = 3; each). Other LR types were 11, 42, 44, 55, 64 and
4.
HPV positive women were younger (33.9 ± 17.0 years) than
he HPV negative ones (41.8 ± 14.7 years; p < 0.001). Other
ocio-demographic characteristics signiﬁcantly associated to
PV infection were: to have a total household income lower
han one Brazilian minimum monthly wage  (p < 0.001), not
o be married (p = 0.014) and to have children (p = 0.016)
Table 1).
Consistent condom use was signiﬁcantly associated to the
PV infection (p < 0.001). Other behavioral characteristics (age
t ﬁrst intercourse, number of lifetime sexual partners, smok-
ng and contraceptive oral use) did not present association
ith HPV detection (Table 2).
Regarding clinical aspects, HPV infection was associated
o the occurrence of cell abnormalities in the Pap smear test
p < 0.001). Further, HPV was more  frequent in women that
nderwent a Pap test in the last twelve months than in the
ther ones (p = 0.031). History of sexually transmitted diseases
nd concurrent vaginal infection were not associated to HPV
nfection.All the above epidemiological variables with a statistical
signiﬁcance in the chi-square test were submitted to the mul-
tivariate analysis (excepting marital status that presented a
high number of missed data and the expected occurrence
of cell abnormalities in the Pap smear test in HPV positive
women). HPV infection was associated to the total household
income lower than one Brazilian minimum monthly wage
(p = 0.001), young age (<30 years old; p = 0.028) and use of con-
dom in all relations (p = 0.023) (Table 3).
In the cytological analysis, most women did not present
cell abnormalities (n = 279; 93%), 243 (87.1%) without HPV and
36 (12.9%) with HPV. Seventeen (5.7%) women presented cells
alterations, fourteen (4.7%) of them only with atypical cells,
one (0.3%) with LSIL and two (0.7%) with HSIL. The patient
with LSIL was infected by HR type 45, while the women  with
HSIL were infected with the HR type 16 and LR type 16 plus
6 (mixed infection). Four samples presented unsatisfactory
cytology results caused by contamination with blood cells, pus
and mucus in over 75% of the smear (Table 4).
In the subgroup of 79 women with two visits, 46 women
(58.2%) showed no HPV infection in both assessments. Almost
all of them (n = 44; 95.7%) had normal Pap smear test on both
visits, but two (4.3%) presented atypical results (one ASC-US
and another ASC-US plus AG-NOS, both in the second visit).
Eighteen (22.8%) women eliminated HPV infection, presenting
normal cells in both Pap smear tests. Only two (2.6%) women
showed conversion to an HPV-DNA positive status, but with-
out cytological alterations. The remaining thirteen (16.4%)
women had persistent HPV infection, most of them with an
HR type in the baseline test (n = 11; 84.6%). All these women
presented normal Pap smear in the ﬁrst visit and ten (76.9%)
had this same result in the second exam, while three (23.1%)
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Table 2 – Analysis of behavioral and clinical characteristics in women according to HPV status.
Variables Overall (n = 300) Without HPV (n = 253) With HPV (n = 47) p-Value*
Age at ﬁrst intercourse 0.248
<18 175 (58.3) 144 (56.9) 31 (66.0)
≥18 125 (41.7) 109 (43.1) 16 (34.0)
Lifetime sex partners 0.147
1 144 (48.0) 126 (49.8) 18 (38.3)
≥2 156 (52.0) 127 (50.2) 29 (61.7)
Smoking 0.674
Yes 39 (13.0) 32 (12.6) 7 (14.9)
No 261 (87.0) 221 (87.4) 40 (85.1)
Contraceptive oral use 0.259
Yes 106 (35.3) 86 (34.0) 20 (42.6)
No 194 (64.7) 167 (66.0) 27 (57.4)
Condom use <0.001
Yes 92 (30.7) 67 (26.5) 25 (53.2)
No 208 (69.3) 186 (73.5) 22 (46.8)
History of STD 0.275
Yes 48 (16.0) 43 (17.0) 5 (10.6)
No 252 (84.0) 210 (83.0) 42 (89.4)
Concurrent vaginal infection 0.977
Yes 57 (19.0) 48 (19.0) 9 (19.1)
No 243 (81.0) 205 (81.0) 38 (80.9)
Last Pap test 0.031
First time 37 (12.3) 27 (10.7) 10 (21.3)
≤1 year 150 (50.0) 124 (49.0) 26 (55.3)
≥2 years 113 (37.7) 102 (40.3) 11 (23.4)
Pap test <0.001
Normal 279 (94.3) 243 (96.1) 36 (76.6)
Abnormal 17 (5.6) 6 (2.3) 11 (23.4)
Unsatisfactory sample 4 (1.4) 4 (1.6) 0 (0.0)
Data are reported as number with percent in parentheses.
∗ 2 test was used to compare between participants.
Table 3 – Multivariate analysis of risk factors to HPV infection in women in South Brazil (n = 300).
Variable PR adjusted CI (95%) p-Value
Age 0.028
≥30 years 1 –
<30 years 2.00 1.08–3.72
Total household income 0.001
>1 Brazilian minimum monthly wage 1 –
≤1 Brazilian minimum monthly wage 2.74 1.55–4.86
Have children 0.438
Yes 1 –
No 1.28 0.68–2.42
Lifetime sexual partner 0.262
1 partner 1  –
≥2 partner 1.36 0.80–2.31
Use of condom in all sexual relations 0.023
No 1 –
Yes 1.87 1.09–3.22
First Pap test 0.761
No 1 –
Yes 0.91 0.48–1.71
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Table 4 – Cytological diagnosis according to the presence of HPV infection.
Cytological diagnosis Without HPV (N = 253) With HPV (N = 47) All women (N = 300)
NILM 243 (96.0) 36 (76.6)a 279 (93.0)
ASC-US 4 (1.6) 6 (12.8)b 10 (3.3)
ASC-H 1 (0.4) 1 (2.1)c 2 (0.7)
ASC-H+AG 0 (0.0) 1 (2.1) 1 (0.3)
LSIL 0 (0.0) 1 (2.1)d 1 (0.3)
HSIL 0 (0.0) 2 (4.3)e 2 (0.7)
AG-NOS 1 (0.4) 0 (0.0) 1 (0.3)
Unsatisfactory sample 4 (1.6) 0 (0.0) 4 (1.4)
Data are reported as number with percent in parentheses. NILM: negative for intraepithelial lesion and malignancy; ASC-US: atypical squamous
cells of undetermined signiﬁcance; ASC-H: atypical squamous cells, cannot exclude high-grade lesion; LSIL: low-grade squamous intraepithelial
lesion; HSIL: high-grade squamous intraepithelial lesion; AG: atypical glandular cells; AG-NOS: atypical glandular cells not otherwise speciﬁed.
a Includes sixteen cases of infection single by HPV types high risk: 16 (3 cases), 31 and 53 (2 cases each), 35, 45, 58, 70, 73 and 82 (1 case each)
and three cases of infection multiple by HPV types 52 and 68; 31 and 45; 55 and 56; also includes seven cases of infection single by only HPV
types low-risk: 6, 11, 42, 44, 64, and 84 (1 case each) and one case infection multiple by HPV types 6 and 81.
b Includes four cases of infection single by HPV types high risk: 31, 52, 56, 59 and two cases of infection multiple by HPV types 16 and 35; 39
and 81.
c Include infection single by HPV type 18.
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resented cells abnormalities. One of these women had AG
ssociated to a persistent infection with HR type 45, another
resented LSIL associated to mixed infections of HR types in
oth visits (18 plus 33 in the ﬁrst test and 16 plus 18 in the
econd one) and the last one presented HSIL with a mixed
nfection of HR type 52 and 73 in the ﬁrst visit and single
nfection with HR type 52 in the follow-up (Table 5).
iscussion
he present work is a cross-sectional study with women
ttended in a public health service in a city from the coun-
ryside from South Brazil. In this region, HPV infection was
ssociated with four socio-demographical (young age, mari-
al status, parity and total household income), one behavioral
consistent condom use) and two clinical (cell alterations in
he Pap test performed in the present study and previous Pap
esting in a period of one year) aspects.
Young age is a classical independent factor associated
o HPV infection and it is well reported in the scientiﬁc
iterature.8,17,18 It is related to the more  intense sexual activity
n this age (that favors the infection) as well as to an anatom-
cal characteristic of the young women (cervical ectopy) that
Table 5 – Course of HPV infection and classiﬁcation of viral type
Course of infection Alla (N = 79) 
Persistence 13 (16.4) 
Clearance 18 (22.8) 
Conversion 2 (2.6) 
No HPV 46 (58.2) 
Data are reported as number with percent in parentheses.
a Includes only women who have had two visits with an interval of at leay HPV 6 and 16.
exposes the columnar epithelium in the ectocervix, making it
more  vulnerable to pathogen infections.19,20
It was also observed a signiﬁcant higher proportion of
single, divorced or widowed than married women with HPV
infection in the bivariate analysis. However this variable was
not included in the multivariate analysis because the limited
data available (n = 99, less than one third of the total sample
population). Other studies have also found this association,
probably because unmarried women have a higher risk behav-
ior than these ones living with a stable partner.21–23
Furthermore, it was found a signiﬁcantly higher proportion
of HPV infected women with children than those without chil-
dren in the bivariate analysis. However this association was
not signiﬁcant in the multivariate analysis. In the literature,
some studies found a positive association10,24,25 while oth-
ers reported no signiﬁcant relation between parity and HPV
infection.6,26
Interestingly, total household income of less than one
minimum Brazilian monthly wage (that means low socio-
economy status) was strongly and signiﬁcantly associated to
HPV infection in the bivariate and even in the multivariate
analyses wage  (p = 0.001). Similar ﬁndings were reported in
other countries27,28 and also in the Northeastern from Brazil.29
Another study also reported that HPV was more  frequent in
 in women from South Brazil.
HPV baseline (N = 33)
High-risk (N = 19) Only Low or indeterminate
risk (N = 14)
9 (47.3) 4 (28.5)
8 (42.2) 10 (71.5)
2 (10.5) 0 (0.0)
– –
st one year in the clinic health service studied.
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public health services than in private clinics, highlighting the
role of the socioeconomic status in HPV infection.30 As a global
context, poverty or insufﬁcient income is a social determinant
for increased vulnerability of women and can either inﬂuence
the adoption of preventive measures against sexually trans-
mitted diseases or reduce the access to information and health
services.31 This reinforces the need for the development of
prevention and control programs in low-income populations.
Several sexual behaviors have been associated to HPV
infection in other Brazilian reports.6,8,32,33 In the present study,
HPV infection was surprisingly associated with consistent
condom use. Condom offers good protection against infec-
tions, but HPV can be transmitted by contact with genital
areas not covered by this preservative.34 Previous studies
have reported a protective effect of condoms in preventing
HPV infection, but without statistical signiﬁcance.35,36 In addi-
tion, misuse or problems with condoms (breakage, slippage
or incomplete use with delayed placement, early removal
and even reuse) are factors that may offer less protection, as
reported previously.37 Condom use may also have been more
reported than effectively done in the practice, considering that
the use is socially desirable.34 Finally, women with new and/or
multiple sexual partners use condoms more  frequently than
those who  only have one regular partner and could be related
to a higher risk behavior as previously reported.34,38
On the other hand, it was not observed association between
HPV infection and the number of lifetime sexual partners, age
at ﬁrst intercourse and history of sexually transmitted dis-
ease and other concomitant genital infection demonstrated
in previous studies.6,32 Another study conducted in the South
Brazil did not ﬁnd association of these characteristics and HPV
infection.39
In the cytological analysis, a low percentage of women
without HPV infection (4.1%) had abnormal Pap smear while
a higher frequency of women with HPV infection (23.4%) pre-
sented atypical cells and/or LSIL/HSIL as expected. Regardless
of the degree of the lesion, all of them presented HR HPV types.
In fact, normal cytology predominates among women without
HPV infection, as shown in previous studies in Brazil7,26,40 and
even in other countries.17,41
HPV persistence in this population was 16.4%. Further, per-
sistent HR HPV types infection was associated with abnormal
Pap smear in three patients (one AG, one HSIL and one LSIL).
The frequency of AG is low, ranging from 0.05% to 2.1%, but
this cytological abnormality has clinical signiﬁcance (several
cases progress to CC).42 On contrast, LSIL and HSIL are rel-
atively common, accounting for 31% and 9.7% (respectively),
among women with cytological abnormal cervical cells.43 In
this situation, HPV-DNA test would be useful to monitor the
occurrence of cervical lesions in women.43–45
Pap smear test is an effective method adopted for the CC
screening and should be performed once a year in each woman
aged 25–64.43 This procedure signiﬁcantly reduced the inci-
dence of cervical cancer in Brazil in the last ﬁve decades.
However several new CC patients have been detected each
year and this disease is still one of the main causes of death
43in women. There is consistent evidence on the performance
of HPV-DNA testing combined with cytological analysis to
detect cervical lesions with more  accuracy. Some countries in
Europe and North America have adopted HPV-DNA testing in 0 1 6;2  0(1):61–68
clinical practice. The latest CC screening guidelines of several
international health institutions recommended the adoption
of cytology and HPV-DNA testing for any woman.46,47 How-
ever, HPV-DNA testing in combination with cytology is not
routinely performed in the public clinics in Brazil. The intro-
duction of HPV-DNA testing could help in the screening of
precursor lesions and in the effective CC control.43,46,48,49
Screening programs for cervical lesions in women have
been implemented in the last decades in Brazil. Such efforts
aim to detect cancer precursor lesions and to provide early
treatment for the patients, reducing the incidence of uterine
cervical cancer in women. The present study was conducted
in one of this public primary health care services located in a
medium-size city from the South of Brazil. Although women of
only one city were included in the study, the majority of them
is of low socioeconomic status, representing women attended
by the health public services in other cities and regions of the
country. In this sense, the data reported here contribute to
a better understanding of the HPV epidemiology and will be
helpful to deﬁne public health policies in Brazil.
In conclusion, the results of this study indicate that age
lower than 30 years and low family socioeconomic status are
associated to HPV infection in women from the countryside
of South Brazil. Further, it was detected a prevalence of HPV
infection of 15.7% and a relatively low HPV persistence (16.4%),
strongly related to CC precursor lesions. HPV-DNA high risk
types detection would help to screen CC in the population.
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